138 related articles for article (PubMed ID: 37013288)
1. Frequency of Nonalcoholic fatty pancreatic disease in patients with carcinoma pancreas presenting for upper abdominal Endoscopic Ultrasound in a tertiary care center.
Qureshi S; Memon F; Chisti N; Ghazanfar S; Quraishy MS
J Pak Med Assoc; 2022 Nov; 72(11):2209-2212. PubMed ID: 37013288
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Nonalcoholic Fatty Pancreas by Endoscopic Ultrasonography.
Sotoudehmanesh R; Tahmasbi A; Sadeghi A; Hosseini H; Mohamadnejad M
Pancreas; 2019 Oct; 48(9):1220-1224. PubMed ID: 31593012
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients: A single-center experience.
Lesmana CRA; Gani RA; Lesmana LA
JGH Open; 2018 Feb; 2(1):4-7. PubMed ID: 30483555
[TBL] [Abstract][Full Text] [Related]
7. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic and hepatobiliary manifestations of nonalcoholic fatty pancreatic disease: a referral multi-center experience.
Sbeit W; Greener T; Kadah A; Mari A; Goldin E; Mahamid M; Khoury T
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e297-e301. PubMed ID: 33600093
[TBL] [Abstract][Full Text] [Related]
9. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population.
Wang CY; Ou HY; Chen MF; Chang TC; Chang CJ
J Am Heart Assoc; 2014 Feb; 3(1):e000297. PubMed ID: 24572250
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
11. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
12. Fatty pancreas disease: clinical impact.
Blaho M; Dítě P; Kunovský L; Martínek A
Vnitr Lek; 2018; 64(10):949-952. PubMed ID: 30590942
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
15. Prediabetes and Type 2 Diabetes are Independent Risk Factors for Computed Tomography-Estimated Nonalcoholic Fatty Pancreas Disease.
Ahbab S; Ünsal A; Ataoğlu HE; Can TS; Kayaş D; Savaş Y
Clinics (Sao Paulo); 2019; 74():e1337. PubMed ID: 31664423
[TBL] [Abstract][Full Text] [Related]
16. Ectopic fat deposition and its related abnormalities of lipid metabolism followed by nonalcoholic fatty pancreas.
Chen Y; Zhang P; Lv S; Su X; Du Y; Xu C; Jin Z
Endosc Ultrasound; 2022; 11(5):407-413. PubMed ID: 35848656
[TBL] [Abstract][Full Text] [Related]
17. The Risk Factors for Acute Pancreatitis after Endoscopic Ultrasound Guided Biopsy.
Ribeiro A; Goel A
Korean J Gastroenterol; 2018 Sep; 72(3):135-140. PubMed ID: 30270595
[TBL] [Abstract][Full Text] [Related]
18. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
Wu WC; Wang CY
Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Pancreas Disease.
Shah N; Rocha JP; Bhutiani N; Endashaw O
Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
[TBL] [Abstract][Full Text] [Related]
20. Environmental Factors Slightly Outweigh Genetic Influences in the Development of Pancreatic Lipid Accumulation: A Classical Twin Study.
Jermendy G; Kolossváry M; Drobni Z; Papp S; Jermendy ÁL; Panajotu A; Dudás I; Tárnoki ÁD; Tárnoki DL; Voros S; Merkely B; Maurovich-Horvat P
Metab Syndr Relat Disord; 2020 Nov; 18(9):413-418. PubMed ID: 32721180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
